Newsroom
Sorted by: Latest
-
USCIS Approves EB-5 Investment Offering for First Solar-Powered Cobalt Processing Facility in U.S.
YUMA, Ariz.--(BUSINESS WIRE)--EVelution Energy LLC ("EVelution Energy" or the “Company”), a U.S. critical minerals company developing America's first commercial-scale, solar-powered cobalt sulfate and cobalt metal processing facility, announced that on September 30, 2026, the United States Citizenship and Immigration Services ("USCIS") approved the project’s EB-5 investment offering, which is expected to support up to approximately US$64.8 million in subordinated project financing. The EB-5 Imm...
-
DemeRx Appoints Ibogaine Pioneer Juan Sanchez-Ramos to Scientific Advisory Board
MIAMI--(BUSINESS WIRE)--DemeRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming addiction therapeutics, today announced the appointment of Juan R. Sanchez-Ramos, M.D., Ph.D., to its Scientific Advisory Board. A neurologist and clinician-scientist whose career has spanned addiction, movement disorders, and neurodegenerative diseases, Dr. Sanchez-Ramos was an early leader in the clinical investigation of ibogaine and a scientific collaborator of DemeRx founder and CEO D...
-
MassMutual Enhances Permanent Life Insurance Portfolio With Launch of Whole Life Guard 10 Pay and Whole Life 95
SPRINGFIELD, Mass.--(BUSINESS WIRE)--MassMutual today announced the introduction of Whole Life Guard 10 Pay and Whole Life 95, two new participating whole life insurance policies designed to help people address a range of long-term financial protection and planning needs. The additions further strengthen MassMutual's whole life insurance portfolio, providing greater choice and flexibility with permanent life insurance coverage. Both policies provide: Lifelong protection Cash value accumulation,...
-
Kairos Pharma Reports Positive, Statistically Significant Interim Efficacy Data from Phase 2 Trial of ENV-105 in Metastatic Prostate Cancer
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company addressing drug resistance in cancer, today announced positive interim efficacy data from its ongoing Phase 2 clinical trial evaluating ENV-105 (carotuximab) in combination with apalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC). The interim analysis demonstrated a statistically significant difference in progression-free survival (PFS) between all...
-
Energy Transfer to Acquire Vaquero Midstream in a $2.625 Billion Transaction
DALLAS--(BUSINESS WIRE)--Energy Transfer LP (Texas Stock Exchange, TXSE: ET) and Vaquero Midstream LLC (Vaquero) announced today that the parties have entered into a definitive agreement pursuant to which Energy Transfer will acquire Vaquero in a bolt-on transaction valued at approximately $2.625 billion. The transaction consideration will consist of $1.95 billion in cash and approximately 33.3 million newly issued Energy Transfer common units. The acquisition is expected to close in the 4th qu...
-
New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1
PARSIPPANY, N.J.--(BUSINESS WIRE)--Drug-resistant heartworm is a growing concern for veterinarians and pet owners as resistant heartworm populations emerge. New research shows that not all heartworm preventives perform equally against these resistant isolates. Macrocyclic lactone (ML) resistance means some heartworm isolates are less sensitive to the drug class used in today’s heartworm disease preventives. As ML resistance continues to challenge heartworm prevention, veterinarians need data th...
-
Vecima Broadband Solutions Recognized in Lightwave’s 2026 Diamond Technology Reviews
VICTORIA, British Columbia--(BUSINESS WIRE)--Vecima announces that three solutions in its Entra broadband access portfolio have received 2026 Diamond Technology Review recognition from Lightwave....
-
Better Home & Finance Holding Company Announces Better 2.0 Shareholder Call
NEW YORK--(BUSINESS WIRE)--Better Home & Finance Holding Company (NASDAQ: BETR; BETRW) (“Better” or the “Company”) today announced it will host a conference call with shareholders on October 6, 2026 at 4:30 PM Eastern Time to discuss the Company’s next chapter under its newly constituted Board, initial progress on its 90-day plan, and priorities for restoring growth and rebuilding shareholder trust. Details to register for the live webcast and to listen to the call by phone will be availabl...
-
Give Back Health Innovation Foundation Supports ScarDx to Advance Non-Invasive Kidney Care
TORONTO--(BUSINESS WIRE)--Give Back Health Innovation Foundation (Give Back), a Canadian philanthropic network advancing public health through innovation and technology, today announced its partnership with ScarDx, a newly formed Ontario health technology company developing a non-invasive way to measure kidney scarring, or fibrosis. Through this partnership, Give Back will provide philanthropic capital aligned with its mission and operating model to support the company as it advances its commer...
-
Tradeweb Reports September 2026 Total Trading Volume of $81.6 Trillion and Average Daily Volume of $3.7 Trillion
NEW YORK--(BUSINESS WIRE)--Tradeweb Markets Inc. (Nasdaq: TW), a global leader in electronic trading across asset classes, today reported total trading volume for the month of September 2026 of $81.6 trillion (tn). Average daily volume (“ADV”) for the month was $3.7tn, an increase of 29.0 percent (%) year-over-year (“YoY”). For the third quarter of 2026, total trading volume was $210.3tn and ADV was $3.2tn, an increase of 22.4% YoY, with preliminary average variable fees per million dollars of...